Edwards Lifesciences (EW) PT Lowered to $90 at Barclays
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
Tweet
Share
E-mailGet Alerts EW Hot Sheet
Price: $95.19 --0%
Rating Summary:
32 Buy, 13 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Rating Summary:
32 Buy, 13 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Join SI Premium – FREE
Barclays analyst Matt Miksic lowered the price target on Edwards Lifesciences (NYSE: EW) to $90.00 (from $97.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Truist Securities Upgrades Edwards Lifesciences (EW) to Buy
- Edwards Lifesciences TAVR trial shows benefit in moderate AS patients
- Increasing unusual option volume: UAA CCOI SHOE SGHC COUR XFOR INTR MXEF MMED EW UTHR
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
